• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Cancer patients, clinicians find value in electronic real-time symptom

Bioengineer by Bioengineer
October 30, 2020
in Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: UNC Lineberger Comprehensive Cancer Center

CHAPEL HILL, N.C.–Both cancer patients and their medical teams found it beneficial when patients shared their symptoms in real time using a web- or telephone-based reporting system, according to a national multi-institutional study.

Ethan Basch, MD, MSc, at the University of North Carolina Lineberger Comprehensive Cancer Center, and his colleagues reported in the journal JCO Clinical Cancer Informatics findings from the PRO-TECT trial, which is evaluating the use of electronic patient-reported outcomes (ePROs) among adults receiving outpatient treatment for advanced and metastatic cancers.

“Our prior research showed that using a web-based system for patients to self-report symptoms to their cancer care team improves patient satisfaction, quality of life, physical function, reduces emergency room visits and lengthens survival,” said Basch, director of UNC Lineberger’s Cancer Outcomes Research Program and the Richard M. Goldberg Distinguished Professor and chief of oncology at the UNC School of Medicine. “However, it has not been clear whether this approach could be widely used in cancer practices across the U.S. or be seen as useful or valuable by patients and providers. It is essential with any strategy for improving care to make sure that people will actually use it and find it valuable.”

In the new study, the researchers conducted a cluster-randomized controlled study at 52 community-based oncology practices across the United States. Half of the practices were assigned to use ePROs as part of the standard of care.

Participants in the study’s intervention arm were prompted every week for a year to report their symptoms and well-being. This involved using a website or an automated telephone program to answer a series of questions about their symptoms, such as pain, nausea and depression, as well as their physical functioning and financial health. The responses had a pre-assigned value on a five-point scale. When a patient reported worsening or severe symptoms, they were sent an email with information on symptom management and a nurse was alerted in real-time to intervene.

To measure whether the ePRO process and information gathered provided value, as well as to identify challenges, the researchers surveyed the patients and clinicians. Patients provided feedback three months after they started on the study and when they completed it. Nurses and physicians shared their assessment on clinical usefulness after they had worked with the system for six months or more.

The majority of the 496 patients surveyed found the PRO-TECT digital ePRO system was easy to understand (95%) and use (93%), and the questions were relevant to their care (91%). Most of the 57 nurses responded that the information was helpful for clinical documentation (79%) and useful for patient care (75%). Of the 39 oncologists surveyed, most found ePRO information useful (91%).

Though clinicians said the ePRO system was useful overall, some reported the information collected had limited value. Sixteen percent of the nurses surveyed said it rarely or never improved discussions with patients, and 14% said it didn’t improve care quality. Nearly 30% of physicians said they rarely used patient-reported information to shape their discussions with patients. Also, some nurses felt they received too many symptom alerts, yet 93% wanted to receive future alerts for severe symptoms.

“There is clearly a lot of enthusiasm from patients to connect to their care team through electronic real-time approaches, and providers also recognize this value, but we know it isn’t perfect,” Basch said. “Our findings lay a path forward for determining the best ways to integrate patient-reported outcomes in oncology practice.”

Basch said a number of issues need to be addressed to encourage clinics and hospitals to consider using ePRO systems. The technology must be easy for patients and providers to use. Workflows may need to be modified to give nurses more time to respond to symptom alerts. Basch said it would be helpful to develop standardized ways to teach patients how to use the system and to remind them of the importance of using it. In addition, it is important to continuously monitor and troubleshoot a program while it is being implemented.

“Patient reported outcomes are well accepted and seen as valuable for quality care by patients and providers, and they improve patient engagement and experience,” Basch said. “Models for health systems to successfully implement PRO programs are needed, likely based on quality improvement approaches. For wide implementation to be effective, a financial model will also be helpful for PROs, most likely through direct reimbursement from insurance companies, or as a key component of value-based alternative payment arrangements between health systems and insurance payers.”

###

Disclosures and Authors

The research was supported in part by the Patient-Centered Outcomes Research Institute (PCORI).

Basch reported holding consulting or advisory roles with Sivan, Carevive Systems, Navigating Cancer, and AstraZeneca. A listing of disclosures for all of the authors is available in the paper.

In addition to Basch, the study’s other authors are Angela M. Stover, PhD, Arlene Chung, MD, MHA, MMCi; Jennifer Jansen, MPH, Sydney Henson, Philip Carr, MPH, Allison Deal, MS, Patricia A. Spears, Mattias Jonsson, Antonia V. Bennett, PhD, Gita Mody, MD, MPH, and Marjory Charlot, MD, UNC Lineberger; Deborah Schrag, MD, Dana-Farber Cancer Institute; Gita Thanarajasingam, MD, and Lisa A. Kottschade, MSN, Mayo Clinic, Rochester, MN; Lauren J. Rogak, MA, Memorial Sloan Kettering Cancer Center; Bryce B. Reeve, PhD, Duke Cancer Institute; Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health; Anna Weiss, MD, Brigham and Women’s Hospital; Deborah Bruner, PhD, Emory University; and Amylou C. Dueck, PhD, and Brenda Ginos, MS, Mayo Clinic, Scottsdale, AZ.

Media Contact
Bill Schaller
[email protected]

Related Journal Article

http://dx.doi.org/10.1200/CCI.20.00081

Tags: cancerInternetMedicine/HealthTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Examining Large-Scale Gene Variants in Parkinson’s

Examining Large-Scale Gene Variants in Parkinson’s

August 1, 2025
blank

Unveiling Concealed Defects in Plastic Electronics Through Molecular Imaging

August 1, 2025

Advanced ANF/MXene-Enhanced Hydrogels Pave the Way for Flexible EMI Shielding and Wearable Sensors

August 1, 2025

Novel Radioimmunotherapy Successfully Targets and Eliminates Cancer Stem Cells in Ovarian Cancer Model

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Examining Large-Scale Gene Variants in Parkinson’s

Unveiling Concealed Defects in Plastic Electronics Through Molecular Imaging

Advanced ANF/MXene-Enhanced Hydrogels Pave the Way for Flexible EMI Shielding and Wearable Sensors

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.